Hepatitis C is a major cause of the UK’s rise in mortality from liver disease, and represents a serious health inequality issue that predominantly affects disadvantaged and marginalised groups.
With the aim of enhancing local service provision and seizing the opportunity for progress provided by a new generation of highly effective hepatitis C drugs, this roadshow is focused on:
- - Showcasing and sharing good practice in the prevention, testing, diagnosis and treatment of hepatitis C
- - Identifying specific issues and potential solutions for tackling hepatitis C in the Brighton and wider Sussex area
The roadshow, held during European HIV - Hepatitis Testing week, will also include a focus on HIV, looking at how HIV and hepatitis C might be addressed together; what lessons can be learnt from how HIV has been addressed, as well as exploring issues around co-infection, ChemSex, MSM and injecting drug use.
The roadshow will include talks on the BBV landscape in Brighton and the wider Sussex area, the commissioning of services, awareness and testing, and opportunities for the elimination of hepatitis C as a major public health concern offered by the new treatments. Afternoon workshops will be held on issues of specific relevance to the local area.
Who should attend:
- - Drug and alcohol professionals
- - Primary and secondary care professionals
- - Local laboratory leads
- - Prison healthcare professionals
- - Commissioners including CCGs and NHS England
- - Directors of public health and their teams
- - Health and wellbeing board representatives
- - Local Public Health England and National Offender Management Service leads
- - Those with an interest in hepatitis C
- - Those with an interest in HIV
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.